On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
On Jun. 4, 2020, iBio announced it had initiatied preclinical immunization studies for its second COVID-19 vaccine platform….
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
On Jun. 4, 2020, Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA)…
On Jun. 3, 2020, in a nationwide study, NIH funded researchers found that the presence of abnormal bundles…
On Jun. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, announced a new…
On Jun. 2, 2020, the NIH reported that early results showed that remdesivir benefited hospitalized patients with severe…
On Jun. 2, 2020, Agenus announced the FDA’s clearance of AgenTus’ IND application for an allogeneic iNKT therapy….
On Jun. 2, 2020, Pfizer announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will…
On Jun. 2, 2020, the USDA announced the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19)…
On Jun. 2, 2020, Albert Einstein College of Medicine announced it had received a $1 million challenge grant…
On Jun. 2, 2020, Trevena announced it had entered into a collaboration with Imperial College London to evaluate…
On Jun. 1, 2020, Resverlogix announced that it is moving forward with a plan to further evaluate apabetaloneï¾’s…
On Jun. 1, 2020, Entos Pharmaceuticals announced a partnership with Cytiva, formerly part of GE Healthcare Life Sciences….
On Jun. 1, 2020, U.S. Dept. of Defense announced it had begun an effort to collect 8,000 donated…
On Jun. 1, 2020, the Government of the Democratic Republic of the Congo announced that a new outbreak…
On Jun. 1, 2020, Gilead Sciences announced topline results from the Phase 3 SIMPLE trial in hospitalized patients…
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced they had synthesized four potential Covid-19 compounds that will…
On Jun. 1, 2020, the USDA announced it is transitioning its virulent Newcastle disease (vND) efforts in southern…
On Jun. 1, 2020, Eli Lilly announced patients had been dosed in the world’s first study of a…
On Jun. 1, 2020, Proteostasis Therapeutics announced results from in vitro studies evaluating the use of PTI-129 as…
On Jun. 1, 2020, the FDA issued an emergency use authorization (EUA) for Impella RP to include patients…
On Jun. 1, 2020, Altimmune announced the FDA had authorized the Company to proceed with a clinical trial…
On Jun. 1, 2020, LabCorpï¾® announced that Covance, its drug development business, had created COVID-19 Clinical Trial Connect…
On Jun. 1, 2020, OPKO Health announced the FDA had authorized OPKO to undertake a Phase 2 trial…
On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…
On Jun. 1, 2020, SIGA Technologies announced its first international delivery of TPOXX (tecovirimat), with 2,500 courses delivered…
On Jun. 1, 2020, PathGroup announced the availability of a new, minimally-invasive nasal swab collection option as a…
On May 29, 2020, the World Health Organization (WHO) announced that thirty countries and multiple international partners and…